Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holger Cario

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Journal of Clinical Medicine|October 13, 2021
Benefits of a Disease Management Program for Sickle Cell Disease in Germany 2011-2019: The Increased Use of Hydroxyurea Correlates with a Reduced Frequency of Acute Chest SyndromeJoachim B Kunz, Andreas Schlotmann, Andrea Daubenbüchel, et al.
Scientific Reports|June 13, 2022
Screening and diagnosis of hemoglobinopathies in Germany: Current state and future perspectivesCarmen Aramayo-Singelmann, Susan Halimeh, Pia Proske, et al.
British Journal of Haematology|June 19, 2008
Clinical and molecular characterisation of a prospectively collected cohort of children and adolescents with polycythemia veraHolger Cario, Klaus Schwarz, Jan M Herter, et al.
Haematologica|September 22, 2016
Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutationsCarme Camps, Nayia Petousi, Celeste Bento, et al.
European Journal of Haematology|September 13, 2023
Long-term haematological response and maintained immunological function after laparoscopic subtotal splenectomy in patients with hereditary spherocytosisAlica L Münch, Eva-Maria Jacobsen, Ansgar Schulz, et al.
Haematologica|October 28, 2021
Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyureaPierre Allard, Nareen Alhaj, Stephan Lobitz, et al.
Nature Genetics|March 17, 2009
JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasmsAmy V Jones, Andrew Chase, Richard T Silver, et al.
European Journal of Haematology|July 1, 2024
The German sickle cell disease registry reveals a surprising risk of acute splenic sequestration and an increased transfusion requirement in patients with compound heterozygous sickle cell disease HbS/β-thalassaemia and no or low HbA expressionPierre Allard, Laura Tagliaferri, Vivienn Weru, et al.
American Journal of Human Genetics|February 12, 2011
Dihydrofolate reductase deficiency due to a homozygous DHFR mutation causes megaloblastic anemia and cerebral folate deficiency leading to severe neurologic diseaseHolger Cario, Desirée E C Smith, Henk Blom, et al.
Psycho-Oncology|August 24, 2019
Fertility knowledge and associated empowerment following an educational intervention for adolescent cancer patientsAnja Borgmann-Staudt, Marina Kunstreich, Ralph Schilling, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Journal of Clinical Medicine|October 13, 2021
Benefits of a Disease Management Program for Sickle Cell Disease in Germany 2011-2019: The Increased Use of Hydroxyurea Correlates with a Reduced Frequency of Acute Chest SyndromeJoachim B Kunz, Andreas Schlotmann, Andrea Daubenbüchel, et al.
Scientific Reports|June 13, 2022
Screening and diagnosis of hemoglobinopathies in Germany: Current state and future perspectivesCarmen Aramayo-Singelmann, Susan Halimeh, Pia Proske, et al.
British Journal of Haematology|June 19, 2008
Clinical and molecular characterisation of a prospectively collected cohort of children and adolescents with polycythemia veraHolger Cario, Klaus Schwarz, Jan M Herter, et al.
Haematologica|September 22, 2016
Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutationsCarme Camps, Nayia Petousi, Celeste Bento, et al.
European Journal of Haematology|September 13, 2023
Long-term haematological response and maintained immunological function after laparoscopic subtotal splenectomy in patients with hereditary spherocytosisAlica L Münch, Eva-Maria Jacobsen, Ansgar Schulz, et al.
Haematologica|October 28, 2021
Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyureaPierre Allard, Nareen Alhaj, Stephan Lobitz, et al.
Nature Genetics|March 17, 2009
JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasmsAmy V Jones, Andrew Chase, Richard T Silver, et al.
European Journal of Haematology|July 1, 2024
The German sickle cell disease registry reveals a surprising risk of acute splenic sequestration and an increased transfusion requirement in patients with compound heterozygous sickle cell disease HbS/β-thalassaemia and no or low HbA expressionPierre Allard, Laura Tagliaferri, Vivienn Weru, et al.
American Journal of Human Genetics|February 12, 2011
Dihydrofolate reductase deficiency due to a homozygous DHFR mutation causes megaloblastic anemia and cerebral folate deficiency leading to severe neurologic diseaseHolger Cario, Desirée E C Smith, Henk Blom, et al.
Psycho-Oncology|August 24, 2019
Fertility knowledge and associated empowerment following an educational intervention for adolescent cancer patientsAnja Borgmann-Staudt, Marina Kunstreich, Ralph Schilling, et al.
Pageof 6